These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20146879)

  • 1. Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation.
    Martinez-Alonso M; Llecha N; Mayorga ME; Sorolla A; Dolcet X; Sanmartin V; Abal L; Casanova JM; Baradad M; Yeramian A; Egido R; Puig S; Vilella R; Matias-Guiu X; Marti RM
    J Int Med Res; 2009; 37(6):1813-22. PubMed ID: 20146879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
    Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
    Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways.
    Zou Y; Xiao X; Li Y; Zhou T
    Oncol Rep; 2009 Feb; 21(2):379-86. PubMed ID: 19148511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of endothelial proliferation by the somatostatin analogue SOM230.
    Adams RL; Adams IP; Lindow SW; Atkin SL
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):431-6. PubMed ID: 15473874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats.
    Schmid HA; Silva AP
    J Endocrinol Invest; 2005; 28(11 Suppl International):28-35. PubMed ID: 16625842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells.
    Pasquali D; Rossi V; Conzo G; Pannone G; Bufo P; De Bellis A; Renzullo A; Bellastella G; Colao A; Vallone G; Bellastella A; Sinisi AA
    J Mol Endocrinol; 2008 Jun; 40(6):263-71. PubMed ID: 18502819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.
    Imhof AK; Glück L; Gajda M; Lupp A; Bräuer R; Schaible HG; Schulz S
    Arthritis Rheum; 2011 Aug; 63(8):2352-62. PubMed ID: 21506098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?
    Ruan W; Fahlbusch F; Clemmons DR; Monaco ME; Walden PD; Silva AP; Schmid HA; Kleinberg DL
    Mol Endocrinol; 2006 Feb; 20(2):426-36. PubMed ID: 16223973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells.
    Mariniello B; Finco I; Sartorato P; Patalano A; Iacobone M; Guzzardo V; Fassina A; Mantero F
    J Endocrinol Invest; 2011 Jun; 34(6):e131-8. PubMed ID: 21042045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
    Ono K; Suzuki T; Miki Y; Taniyama Y; Nakamura Y; Noda Y; Watanabe M; Sasano H
    Anticancer Res; 2007; 27(4B):2231-9. PubMed ID: 17695508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
    Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
    J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and functional significance of somatostatin receptors in malignant melanoma.
    Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
    World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
    Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
    J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ghrelin secretion by somatostatin analogs in rats.
    Silva AP; Bethmann K; Raulf F; Schmid HA
    Eur J Endocrinol; 2005 Jun; 152(6):887-94. PubMed ID: 15941929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro.
    Lesche S; Lehmann D; Nagel F; Schmid HA; Schulz S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):654-61. PubMed ID: 19001514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors.
    Streuli J; Harris AG; Cottiny C; Allagnat F; Daly AF; Grouzmann E; Abid K
    Neuropeptides; 2018 Apr; 68():84-89. PubMed ID: 29523357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
    Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
    Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.